Preclinical Research

Boston Scientific partnered with some of the world’s most renowned researchers to thoroughly evaluate the SYNERGY Stent’s design and its ability to heal. As a result, preclinical research is showing evidence that the SYNERGY Stent’s bioabsorbable polymer, abluminally coated design, reduces inflammation and improves endothelial coverage and function compared to permanent polymer conformally coated stents.*